Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 1/20 | 0.42 |
| ▸ | NOS2 | P35228 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 6/20 | 0.39 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 5/20 | 0.39 |
| ▸ | GRN | P28799 | 1/20 | 0.38 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.38 |
| ▸ | GRM6 | O15303 | 1/20 | 0.38 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.38 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL561163 | 1.00 | MAPK1 (0.44) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| SCHEMBL1644294 | 1.00 | MAPK1 (0.44) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL920376 | 0.98 | MAPK1 (0.43) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL919391 | 0.98 | MAPK1 (0.43) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| Hydrochloric Acid SCHEMBL920374 | 0.98 | MAPK1 (0.43) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| SCHEMBL30589488 | 0.98 | MAPK1 (0.43) | MAPK1SLC7A5NOS3NOS1NOS2 | |
| SCHEMBL31276487 | 0.84 | SLC7A5 (0.41) | SLC7A5NOS3NOS1NOS2GRIK1 | |
| SCHEMBL16449782 | 0.83 | MAPK1 (0.46) | MAPK1SLC7A5GRNSORT1 | |
| SCHEMBL16449784 | 0.83 | MAPK1 (0.46) | MAPK1SLC7A5GRNSORT1 | |
| SCHEMBL16450884 | 0.82 | MAPK1 (0.44) | MAPK1SLC7A5NOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025100405-A1 | MACROCYCLIC PEPTIDE COMPOUND HAVING CELL MEMBRANE PERMEABILITY AND METABOLIC STABILITY, AND LIBRARY CONTAINING SAME | 中外製薬株式会社 | 2025-05-15 | — | — | WO | claimed |
| EP-4532508-A1 | 3-AZASTEROID COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO MITOCHONDRIAL FUNCTION | NZP UK Limited (GB) | 2025-04-09 | — | — | EP | claimed |
| CN-119529056-A | Solid phase preparation method of telipopeptide | 福建基诺厚普生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119350450-A | Water-based synthesis method of mu-conotoxin KIIIA with instant wrinkle removal effect | 润辉生物技术（威海）有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-117986349-B | Semex lattice preparation method of lupeptide | 福建基诺厚普生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| WO-2024134676-A1 | PROCESS FOR THE PREPARATION OF TIRZEPATIDE | DR. REDDY’S LABORATORIES LIMITED (IN) | 2024-06-27 | — | — | WO | claimed |
| CN-117986349-A | Preparation method of semaglutin | 福建基诺厚普生物科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | PEKING UNIVERSITY (CN) | 2024-03-21 | — | — | US | claimed |
| WO-2024017317-A1 | HER2 TARGETING PEPTIDE MOLECULE AND USE THEREOF | 中国科学院上海药物研究所 | 2024-01-25 | — | — | WO | claimed |
| WO-2023233164-A1 | 3-AZASTEROID COMPOUNDS FOR THE TREATMENT OF DISEASES RELATED TO MITOCHONDRIAL FUNCTION | NZP UK Limited (GB) | 2023-12-07 | — | — | WO | claimed |
| EP-1088020-A1 | FUNCTIONALISED POLYMERS OF ALPHA-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | USTAV MAKROMOLEKULARNI CHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) | 2001-04-04 | — | — | EP | claimed |
| WO-1999064495-A1 | FUNCTIONALISED POLYMERS OF α-AMINO ACIDS AND THE METHOD OF PREPARATION THEREOF | ÚSTAV MAKROMOLEKULÁRNÍ CHEMIE AKADEMIE VĚD ČESKÉ REPUBLIKY (CZ) | 1999-12-16 | — | — | WO | claimed |
| EP-0751765-A4 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA INC (US) | 1997-05-28 | — | — | EP | claimed |
| US-5618825-A | ENZYME INHIBITORS; ANTICOAGULANTS; VISION DISORDERS | PHARMACOPEIA, INC. (US) | 1997-04-08 | — | — | US | claimed |
| EP-0751765-A1 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA, INC. (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1995024186-A1 | SULFONAMIDE DERIVATIVES AND THEIR USE | PHARMACOPEIA, INC. (US) | 1995-09-14 | — | — | WO | claimed |
| EP-0594656-A1 | 4-AMINO-3-HYDROXYCARBOXYLIC ACID DERIVATIVES | SANDOZ LTD. (CH) | 1994-05-04 | — | — | EP | claimed |
| WO-1993001166-A1 | 4-AMINO-3-HYDROXYCARBOXYLIC ACID DERIVATIVES | SANDOZ LTD. (CH) | 1993-01-21 | — | — | WO | claimed |
| US-4960881-A | REACTING AMINO ACID WITH ALPHA-CHLORINATED CARBONATE IN SOLVENT IN PRESENCE OF ACID SCAVENGER | SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) | 1990-10-02 | — | — | US | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092830-A1 | PROCESS FOR PREPARING CARBOXYL CYCLIC ACID ANHYDRIDE | CA9, CA7, APEH | MAPK1 2650/4885SLC7A5 393/4885NOS3 1256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.